Oncogene

Oncogene

癌基因

  • 1区 中科院分区
  • Q1 JCR分区

期刊简介

《Oncogene》是由Springer Nature出版社于1997年创办的英文国际期刊(ISSN: 0950-9232,E-ISSN: 1476-5594),该期刊长期致力于生化与分子生物学领域的创新研究,主要研究方向为医学-生化与分子生物学。作为SCIE收录期刊(JCR分区 Q1,中科院 1区),本刊采用OA未开放获取模式(OA占比0.3491...%),以发表生化与分子生物学领域等方向的原创性研究为核心(研究类文章占比85.71%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在266篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Oncogene审稿周期约为 约1.0个月 。该刊近年未被列入国际预警名单,年发文量约266篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 266 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 GENETICS & HEREDITY 遗传学 CELL BIOLOGY 细胞生物学 ONCOLOGY 肿瘤学
1区 1区 2区 2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 GENETICS & HEREDITY 遗传学 ONCOLOGY 肿瘤学 CELL BIOLOGY 细胞生物学
1区 1区 1区 2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:BIOCHEMISTRY & MOLECULAR BIOLOGY SCIE Q1 36 / 313

88.7%

学科:CELL BIOLOGY SCIE Q1 40 / 205

80.7%

学科:GENETICS & HEREDITY SCIE Q1 16 / 191

91.9%

学科:ONCOLOGY SCIE Q1 42 / 322

87.1%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:BIOCHEMISTRY & MOLECULAR BIOLOGY SCIE Q1 32 / 313

89.94%

学科:CELL BIOLOGY SCIE Q1 29 / 205

86.1%

学科:GENETICS & HEREDITY SCIE Q1 18 / 191

90.84%

学科:ONCOLOGY SCIE Q1 43 / 322

86.8%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:15.3 SJR:2.334 SNIP:1.368
学科类别 分区 排名 百分位
大类:Biochemistry, Genetics and Molecular Biology 小类:Genetics Q1 18 / 347

94%

大类:Biochemistry, Genetics and Molecular Biology 小类:Molecular Biology Q1 35 / 410

91%

大类:Biochemistry, Genetics and Molecular Biology 小类:Cancer Research Q1 25 / 230

89%

期刊发文

  • TNF alpha-induced IDH1 hyperacetylation reprograms redox homeostasis and promotes the chemotherapeutic sensitivity

    Author: Yang, Hao; Zhao, Xiaoping; Liu, Jianjun; Jin, Mingming; Liu, Xiyu; Yan, Jun; Yao, Xufeng; Mao, Xinyi; Li, Nan; Liang, Beibei; Xie, Wei; Zhang, Kunchi; Zhao, Jian; Liu, Liu; Huang, Gang

    Journal: ONCOGENE. 2023; Vol. 42, Issue 1, pp. 35-48. DOI: 10.1038/s41388-022-02528-y

  • Therapeutic targeting the oncogenic driver EWSR1::FLI1 in Ewing sarcoma through inhibition of the FACT complex

    Author: Mo, Jialin; Tan, Kezhe; Dong, Yu; Lu, Wenjie; Liu, Fang; Mei, Yanqing; Huang, Hongting; Zhao, Kewen; Lv, Zhibao; Ye, Youqiong; Tang, Yujie

    Journal: ONCOGENE. 2023; Vol. 42, Issue 1, pp. 11-25. DOI: 10.1038/s41388-022-02533-1

  • TARDBP promotes ovarian cancer progression by altering vascular endothelial growth factor splicing

    Author: He, Yutian; OuYang, Zhenbo; Liu, Wenwen; Chen, Yu; Zhang, Qiushi

    Journal: ONCOGENE. 2023; Vol. 42, Issue 1, pp. 49-61. DOI: 10.1038/s41388-022-02539-9

  • AGO4 suppresses tumor growth by modulating autophagy and apoptosis via enhancing TRIM21-mediated ubiquitination of GRP78 in a p53-independent manner

    Author: Wang, Lin; Li, Da; Su, Xueting; Zhao, Yuechao; Huang, Aixue; Li, Hui; Li, Jie; Xia, Wei; Jia, Tianqi; Zhang, Hongwen; Dong, Jie; Liu, Xuemei; Shao, Ningsheng

    Journal: ONCOGENE. 2023; Vol. 42, Issue 1, pp. 62-77. DOI: 10.1038/s41388-022-02526-0

  • CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1

    Author: Li, Dongbao; Wang, Yuhong; Dong, Chao; Chen, Tao; Dong, Anqi; Ren, Jiayu; Li, Weikang; Shu, Gege; Yang, Jiaoyang; Shen, Wenhao; Qin, Lei; Hu, Lin; Zhou, Jin

    Journal: ONCOGENE. 2023; Vol. 42, Issue 2, pp. 83-98. DOI: 10.1038/s41388-022-02537-x

  • Adaptive activation of EFNB2/EPHB4 axis promotes post-metastatic growth of colorectal cancer liver metastases by LDLR-mediated cholesterol uptake

    Author: Xu, Chunjie; Gu, Lei; Kuerbanjiang, Manzila; Jiang, Chunhui; Hu, Lipeng; Liu, Ye; Xue, Hanbing; Li, Jun; Zhang, Zhigang; Xu, Qing

    Journal: ONCOGENE. 2023; Vol. 42, Issue 2, pp. 99-112. DOI: 10.1038/s41388-022-02519-z

  • A micropeptide JunBP regulated by TGF-beta promotes hepatocellular carcinoma metastasis

    Author: Zhang, Hongwei; Liao, Zhibin; Wang, Weijian; Liu, Yachong; Zhu, He; Liang, Huifang; Zhang, Bixiang; Chen, Xiaoping

    Journal: ONCOGENE. 2023; Vol. 42, Issue 2, pp. 113-123. DOI: 10.1038/s41388-022-02518-0

  • Hypoxia-induced circADAMTS6 in a TDP43-dependent manner accelerates glioblastoma progression via ANXA2/ NF-kappa B pathway

    Author: Zhao, Shulin; Li, Boyan; Zhao, Rongrong; Pan, Ziwen; Zhang, Shouji; Qiu, Wei; Guo, Qindong; Qi, Yanhua; Gao, Zijie; Fan, Yang; Xu, Hao; Li, Ming; Zhang, Jian; Wang, Huizhi; Xu, Jianye; Wang, Shaobo; Wang, Qingtong; Qiu, Jiawei; Deng, Lin; Guo, Xing; Zhang, Ping; Xue, Hao; Li, Gang

    Journal: ONCOGENE. 2023; Vol. 42, Issue 2, pp. 138-153. DOI: 10.1038/s41388-022-02542-0